6533b86efe1ef96bd12cc7b6
RESEARCH PRODUCT
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY
Sophie BernardCaterina StelitanoCatherine ThieblemontKamal BouabdallahMichele MerliM. PonzoniAnna Marina LiberatiAlexandra Traverse-glehenEmanuele ZuccaSacchi Samantha PozziK. BeldjordEmilio IannittoPierre FeugierM. LadettoBenoit TessoulinLucile BaseggioMarina CesarettiDaniela DrandiBarbara CastagnariClaudio TripodoRemy GressinMaria Giuseppina CabrasSimone FerreroIsabel AlvarezC. Pattisubject
Cancer Researchmedicine.medical_specialtyOncologybusiness.industryMedicinePhases of clinical researchHematologyGeneral MedicineSplenic marginal zone lymphomaRadiologybusinessmedicine.diseaseMinimal residual diseaseyear | journal | country | edition | language |
---|---|---|---|---|
2019-06-01 | Hematological Oncology |